Orapaz
NDC 73614-417, Cephalexin, Ibuprofen, Chlorhexidine Gluconate, kit, from Brisk Pharmaceuticals.
- Product NDC
- 73614-417
- Status
- Listed
- Labeler
- Brisk Pharmaceuticals
- Dosage form
- KIT
- Route
- —
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- UNAPPROVED DRUG OTHER
- Application
- —
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/73614-417 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
None listed.
| Package NDC | NDC-11 | Package |
|---|---|---|
| 73614-417-03 | 73614041703 | 1 KIT in 1 CARTON (73614-417-03) * 30 CAPSULE in 1 BOTTLE (73614-202-03) * 30 TABLET, FILM COATED in 1 BOTTLE (73614-201-03) * 118 mL in 1 BOTTLE (73614-203-01) * 118 mL in 1 BOTTLE (73614-203-01) |
Linked data
RxNorm, label and prices
RxNorm concepts
RxNorm links no concept to this product's packages.
Related lookups
FDA label sections
GET /v1/drugs/labels/2de0b332-58a3-0bb4-e063-6394a90a1a45
Use it
Look up 73614-417 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/73614-417 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 73614-417. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.